Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease

Neurobiology of Aging

Volumn 36, Issue 12, 2015, Pages 3121-3129

  Mastroeni, Diego ^a,b,c   Delvaux, Elaine ^a,b   Nolz, Jennifer ^a,b   Tan, Yuyan ^d   Grover, Andrew ^b   Oddo, Salvatore ^b,e   Coleman, Paul D ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Epigenetics; H3k4me3; Localization

Indexed keywords

HISTONE 3 TRIMETHYLATION ON LYSINE 4; HISTONE H3; MARKER; MC1 PROTEIN; PG5 PROTEIN; UNCLASSIFIED DRUG; HISTONE; LYSINE;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAAK STAGE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; EPIGENETICS; FEMALE; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STAGING; VERY ELDERLY; WESTERN BLOTTING; GENE EXPRESSION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METHYLATION; MIDDLE AGED; TRANSCRIPTION INITIATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HISTONES; HUMANS; LYSINE; MALE; METHYLATION; MIDDLE AGED; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84946595097     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.08.017     Document Type: Article

References (39)

1. Augustinack J.C., Schneider A., Mandelkow E.M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 2002, 103:26-35.
2. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2002, 21:381-395.
3. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
4. Beach T.G., Sue L.I., Walker D.G., Roher A.E., Lue L., Vedders L., Connor D.J., Sabbagh M.N., Rogers J. The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 2008, 9:229-245.
5. Berchtold N.C., Coleman P.D., Cribbs D.H., Rogers J., Gillen D.L., Cotman C.W. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol. Aging 2013, 34:1653-1661.
6. Berger S.L. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 2002, 12:142-148.
7. Bernstein B.E., Kellis M. Large-scale discovery and validation of functional elements in the human genome. Genome Biol. 2005, 6:312.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
9. Braak H., Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 2011, 121:171-181.
10. Braak H., Thal D.R., Ghebremedhin E., Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 2011, 70:960-969.
11. Cheung I., Shulha H.P., Jiang Y., Matevossian A., Wang J., Weng Z., Akbarian S. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8824-8829.
12. Cruceanu C., Freemantle E., Alda M., Rouleau G.A., Turecki G. Epigenetic regulation of synapsin genes in mood disorders. Neuropsychopharmacology 2013, 38:239-241.
13. Davies P. Characterization and use of monoclonal antibodies to tau and paired helical filament tau. Methods Mol. Med. 2000, 32:361-373.
14. Desplats P., Spencer B., Coffee E., Patel P., Michael S., Patrick C., Adame A., Rockenstein E., Masliah E. Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J. Biol. Chem. 2011, 286:9031-9037.
15. Espada J., Esteller M. Epigenetic control of nuclear architecture. Cell Mol. Life Sci. 2007, 64:449-457.
16. Facchinetti P., Dorard E., Contremoulins V., Gaillard M.C., Deglon N., Sazdovitch V., Guihenneuc-Jouyaux C., Brouillet E., Duyckaerts C., Allinquant B. SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients. Neurobiol. Aging 2014, 35:958-968.
17. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007, 23:413-418.
18. Gilbert N., Thomson I., Boyle S., Allan J., Ramsahoye B., Bickmore W.A. DNA methylation affects nuclear organization, histone modifications, and linker histone binding but not chromatin compaction. J. Cell Biol. 2007, 177:401-411.
19. Gupta S., Kim S.Y., Artis S., Molfese D.L., Schumacher A., Sweatt J.D., Paylor R.E., Lubin F.D. Histone methylation regulates memory formation. J. Neurosci. 2010, 30:3589-3599.
20. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001, 21:3017-3023.
21. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33(Suppl):245-254.
22. Jicha G.A., Lane E., Vincent I., Otvos L., Hoffmann R., Davies P. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 1997, 69:2087-2095.
23. Jicha G.A., Weaver C., Lane E., Vianna C., Kress Y., Rockwood J., Davies P. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 1999, 19:7486-7494.
24. Kamikawa Y.F., Donohoe M.E. The localization of histone H3K27me3 demethylase Jmjd3 is dynamically regulated. Epigenetics 2014, 9:834-841.
25. Kim J.Y., Casaccia P. HDAC1 in axonal degeneration: a matter of subcellular localization. Cell Cycle 2010, 9:3680-3684.
26. Kim J.Y., Shen S., Dietz K., He Y., Howell O., Reynolds R., Casaccia P. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat. Neurosci. 2010, 13:180-189.
27. Lou S., Lee H.M., Qin H., Li J.W., Gao Z., Liu X., Chan L.L., Kl Lam V., So W.Y., Wang Y., Lok S., Wang J., Ma R.C., Tsui S.K., Chan J.C., Chan T.F., Yip K.Y. Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation. Genome Biol. 2014, 15:408.
28. Mastroeni D., Chouliaras L., Grover A., Liang W.S., Hauns K., Rogers J., Coleman P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009, 4:e6617.
29. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2010, 31:2025-2037.
30. Mastroeni D., McKee A., Grover A., Rogers J., Coleman P.D. Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology. PLoS One 2013, 8:e53349.
31. Nixon R.A. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging 2005, 26:373-382.
32. Oddo S., Caccamo A., Kitazawa M., Tseng B.P., LaFerla F.M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging 2003, 24:1063-1070.
33. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
34. Ogawa O., Zhu X., Lee H.G., Raina A., Obrenovich M.E., Bowser R., Ghanbari H.A., Castellani R.J., Perry G., Smith M.A. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?. Acta Neuropathol. 2003, 105:524-528.
35. Perl D.P. Neuropathology of Alzheimer's disease. Mt. Sinai J. Med. 2010, 77:32-42.
36. Sims R.J., Millhouse S., Chen C.F., Lewis B.A., Erdjument-Bromage H., Tempst P., Manley J.L., Reinberg D. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 2007, 28:665-676.
37. Thatcher K.N., LaSalle J.M. Dynamic changes in histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics 2006, 1:24-31.
38. Wang J.Z., Xia Y.Y., Grundke-Iqbal I., Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheimers Dis. 2013, 33(Suppl 1):S123-S139.
39. Weaver C.L., Espinoza M., Kress Y., Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 2000, 21:719-727.